Company intelligence / Profile preview
Jiangxi Jingtong Meilian Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Jiangxi Jingtong Meilian Pharmaceutical manufactures and markets pharmaceutical products including small molecule generics like norfloxacin capsules as well as traditional Chinese medicines such as Chaihuang Granules and Fuke Zhidai Pian. The company supplies to hospitals, pharmacies, and clinics in China. No clinical trial or novel drug development data found; focus appears to be on commercialized generic drugs and TCMs
- Therapeutic areas
- Women's HealthInfectious Diseases
- Modalities
- Small moleculeHerbal medicine
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Jiangxi Jingtong Meilian Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangxi Jingtong Meilian Pharmaceutical.